Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 28/2/2020
SIETES contiene 92917 citas

 
 
 1 a 8 de 8 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Berendt L, Hakansson C, Bach KF, Dalhoff K, Andreasen PB, Petersen LG, Andersen E, Poulsen HE. Effect of European Clinical Trials Directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency, 1993-2006. BMJ 2008;336:33-5. [Ref.ID 81953]
2.
Glintborg B, Andersen SE, Spang-Hanssen E, Dalhoff K. Disregarded use of herbal medical products and dietary supplements among surgical and medical patients as estimated by home inspection and interview. Pharmacoepidemiol Drug Saf 2005;14:639-45. [Ref.ID 75029]
3.
Glintborg B, Andersen SE, Spang-Hanssen E, Dalhoff K. The use of over-the-counter drugs among surgical and medical patients. Eur J Clin Pharmacol 2004;60:431-7. [Ref.ID 71395]
4.Tiene citas relacionadas Cita con resumen
Schmidt LE, Knudsen TT, Dalhoff K, Bendtsen F. Effect of paracetamol poisoning on international normalised ratio. Authors' reply. Lancet 2003;361:429-30. [Ref.ID 64883]
5.Tiene citas relacionadas Cita con resumen
Schmidt LE, Knudsen TT, Dalhoff K, Bendtsen F. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet 2002;360:1151-2. [Ref.ID 63634]
6. Cita con resumen
Schmidt LE, Dalhoff K. Food-drug interactions. Drugs 2002;62:1481-502. [Ref.ID 62177]
7.
Schmidt LE, Dalhoff K. Concomitant overdosing of other drugs in patients with paracetamol poisoning. Br J Clin Pharmacol 2002;53:535-41. [Ref.ID 61777]
8. Cita con resumen
Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001;51:87-91. [Ref.ID 54785]
Seleccionar todas
 
 1 a 8 de 8